Knowledge

Susanna Dunachie

Source đź“ť

33: 171:
Dunachie works in infectious diseases and vaccines, particularly attempting to improve the immune responses of people suffering from diabetes. She performs research in tropical countries, where she combines microbiology and immunology to accelerate the discovery of vaccines. In particular, Dunachie
164:, where she worked in the Mahidol Oxford Tropical Medicine Research Unit. She returned to the University of Oxford in 2015, where she headed the Tropical Immunology Group. In 2020 she was appointed as Global Research Professor by the 313:
Jordan R. Barrett; Sandra Belij-Rammerstorfer; Christina Dold; et al. (17 December 2020). "Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses".
234:
to investigate how immunocompromised patients respond to the vaccinations. Her hope is that the insight she gains from this work will facilitate the design of vaccinations against
254:"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK" 185: 129: 663: 108:. Her work considers microbiology and immunology to better understand bacterial infection and accelerate the development of vaccines. She has focused on 211: 648: 165: 148:
searching for malaria vaccines. She remained at the University of Oxford throughout her early career, working as a specialist registrar in the
215: 611: 653: 643: 586: 206:
Dunachie leads the Protective Immunity for T cells in Healthcare workers (PITCH) study, which explores immune responses to the
428: 359: 32: 612:"New study finds strong immune response following Covid-19 vaccination | News | The University of Sheffield" 149: 658: 506: 587:"Longer interval between the first and second Pfizer vaccine boosts antibody levels and 'helper' T cells" 141: 105: 71: 85:
Malaria vaccines and microarrays : clinical and laboratory evaluation of two vaccine regimens.
394: 376: 333: 293: 275: 192: 145: 144:, where she studied medicine. After graduating, she worked as a clinical research fellow with 46: 402: 384: 368: 353:
Barbara Kronsteiner; Panjaporn Chaichana; Manutsanun Sumonwiriya; et al. (8 May 2019).
341: 325: 301: 283: 267: 207: 456: 316: 389: 354: 288: 253: 231: 219: 203:. In particular, diabetic patients appeared to be more susceptible to severe disease. 271: 637: 195:, Dunachie switched her focus to investigating SARS‑CoV‑2, with a specific focus on 481: 249: 181: 177: 117: 113: 235: 173: 109: 536: 329: 258: 227: 380: 337: 279: 199:
immunity. At the time it was unclear what role T cells played in immunity to
345: 305: 398: 297: 104:
is a British microbiologist who is Professor of Infectious Diseases at the
406: 372: 84: 355:"Diabetes alters immune response patterns to acute melioidosis in humans" 200: 121: 561: 223: 161: 196: 125: 78: 160:
After completing her specialist training, Dunachie moved to
37:
Dunachie interviewed for Tropical Medicine Oxford in 2015
429:"What Have We Learned About Immunity to SARS-CoV-2?" 77: 67: 59: 42: 23: 186:severe acute respiratory syndrome coronavirus 2 130:severe acute respiratory syndrome coronavirus 2 140:Dunachie was an undergraduate student at the 8: 31: 20: 388: 287: 420: 248:Merryn Voysey; Sue Ann Costa Clemens; 222:, but also worked with researchers in 166:National Institute for Health Research 7: 531: 529: 527: 451: 449: 212:Oxford–AstraZeneca COVID-19 vaccine 664:Alumni of the University of Oxford 507:"Current NIHR Research Professors" 14: 252:; et al. (8 December 2020). 216:Pfizer–BioNTech COVID-19 vaccine 360:European Journal of Immunology 1: 649:British women microbiologists 272:10.1016/S0140-6736(20)32661-1 680: 330:10.1038/S41591-020-01179-4 210:. She has focused on the 95: 52: 30: 654:NIHR Research Professors 591:University of Birmingham 461:www.validate-network.org 136:Early life and education 644:British microbiologists 150:John Radcliffe Hospital 124:pandemic, she studied 16:British microbiologist 373:10.1002/EJI.201848037 242:Selected publications 102:Susanna Jane Dunachie 25:Susanna Jane Dunachie 486:www.medawar.ox.ac.uk 142:University of Oxford 106:University of Oxford 72:University of Oxford 616:www.sheffield.ac.uk 566:www.pitch-study.org 191:In response to the 156:Research and career 537:"Susanna Dunachie" 482:"Susanna Dunachie" 457:"Susanna Dunachie" 230:. She worked with 266:(10269): 99–111. 208:COVID-19 vaccines 193:COVID-19 pandemic 146:Adrian V. S. Hill 99: 98: 54:Scientific career 47:Oxford University 671: 628: 627: 625: 623: 608: 602: 601: 599: 597: 583: 577: 576: 574: 572: 558: 552: 551: 549: 547: 541:www.jenner.ac.uk 533: 522: 521: 519: 517: 503: 497: 496: 494: 492: 478: 472: 471: 469: 467: 453: 444: 443: 441: 439: 425: 410: 392: 367:(7): 1092–1106. 349: 309: 291: 91: 35: 21: 679: 678: 674: 673: 672: 670: 669: 668: 634: 633: 632: 631: 621: 619: 618:. 26 March 2021 610: 609: 605: 595: 593: 585: 584: 580: 570: 568: 560: 559: 555: 545: 543: 535: 534: 525: 515: 513: 505: 504: 500: 490: 488: 480: 479: 475: 465: 463: 455: 454: 447: 437: 435: 427: 426: 422: 417: 352: 317:Nature Medicine 312: 247: 244: 158: 138: 89: 43:Alma mater 38: 26: 17: 12: 11: 5: 677: 675: 667: 666: 661: 656: 651: 646: 636: 635: 630: 629: 603: 578: 553: 523: 511:www.nihr.ac.uk 498: 473: 445: 419: 418: 416: 413: 412: 411: 350: 324:(2): 279–288. 310: 250:Shabir A Madhi 243: 240: 232:Eleanor Barnes 220:United Kingdom 172:has worked on 157: 154: 137: 134: 97: 96: 93: 92: 81: 75: 74: 69: 65: 64: 61: 57: 56: 50: 49: 44: 40: 39: 36: 28: 27: 24: 15: 13: 10: 9: 6: 4: 3: 2: 676: 665: 662: 660: 659:Living people 657: 655: 652: 650: 647: 645: 642: 641: 639: 617: 613: 607: 604: 592: 588: 582: 579: 567: 563: 562:"PITCH Study" 557: 554: 542: 538: 532: 530: 528: 524: 512: 508: 502: 499: 487: 483: 477: 474: 462: 458: 452: 450: 446: 434: 430: 424: 421: 414: 408: 404: 400: 396: 391: 386: 382: 378: 374: 370: 366: 362: 361: 356: 351: 347: 343: 339: 335: 331: 327: 323: 319: 318: 311: 307: 303: 299: 295: 290: 285: 281: 277: 273: 269: 265: 261: 260: 255: 251: 246: 245: 241: 239: 237: 233: 229: 225: 221: 217: 213: 209: 204: 202: 198: 194: 189: 187: 183: 179: 175: 169: 167: 163: 155: 153: 151: 147: 143: 135: 133: 131: 127: 123: 120:. During the 119: 115: 111: 107: 103: 94: 87: 86: 82: 80: 76: 73: 70: 66: 62: 58: 55: 51: 48: 45: 41: 34: 29: 22: 19: 620:. Retrieved 615: 606: 594:. Retrieved 590: 581: 569:. Retrieved 565: 556: 544:. Retrieved 540: 514:. Retrieved 510: 501: 489:. Retrieved 485: 476: 464:. Retrieved 460: 436:. Retrieved 432: 423: 364: 358: 321: 315: 263: 257: 205: 190: 182:tuberculosis 178:scrub typhus 170: 159: 139: 128:immunity to 118:tuberculosis 114:scrub typhus 101: 100: 83: 68:Institutions 53: 18: 622:24 December 596:24 December 571:24 December 546:24 December 466:24 December 438:24 December 236:melioidosis 174:melioidosis 110:melioidosis 63:Vaccinology 638:Categories 516:8 February 491:8 February 415:References 346:Q109919407 306:Q104286457 259:The Lancet 228:Bangladesh 407:Q91591024 381:0014-2980 338:1078-8956 280:0140-6736 403:Wikidata 399:31032897 342:Wikidata 302:Wikidata 298:33306989 214:and the 201:COVID-19 168:(NIHR). 122:COVID-19 390:6618312 289:7723445 224:Vietnam 218:in the 162:Bangkok 152:trust. 405:  397:  387:  379:  344:  336:  304:  296:  286:  278:  197:T cell 126:T cell 90:(2007) 88:  79:Thesis 60:Fields 433:issuu 624:2021 598:2021 573:2021 548:2021 518:2022 493:2022 468:2021 440:2021 395:PMID 377:ISSN 334:ISSN 294:PMID 276:ISSN 226:and 184:and 116:and 385:PMC 369:doi 326:doi 284:PMC 268:doi 264:397 640:: 614:. 589:. 564:. 539:. 526:^ 509:. 484:. 459:. 448:^ 431:. 401:. 393:. 383:. 375:. 365:49 363:. 357:. 340:. 332:. 322:27 320:. 300:. 292:. 282:. 274:. 262:. 256:. 238:. 188:. 180:, 176:, 132:. 112:, 626:. 600:. 575:. 550:. 520:. 495:. 470:. 442:. 409:. 371:: 348:. 328:: 308:. 270::

Index


Oxford University
University of Oxford
Thesis
Malaria vaccines and microarrays : clinical and laboratory evaluation of two vaccine regimens.
University of Oxford
melioidosis
scrub typhus
tuberculosis
COVID-19
T cell
severe acute respiratory syndrome coronavirus 2
University of Oxford
Adrian V. S. Hill
John Radcliffe Hospital
Bangkok
National Institute for Health Research
melioidosis
scrub typhus
tuberculosis
severe acute respiratory syndrome coronavirus 2
COVID-19 pandemic
T cell
COVID-19
COVID-19 vaccines
Oxford–AstraZeneca COVID-19 vaccine
Pfizer–BioNTech COVID-19 vaccine
United Kingdom
Vietnam
Bangladesh

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑